Skip to content

Clinical trials

Hematologic Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Diseases Country / region: South Korea Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20112
20122
20132
20143
20151
20172
20185
20191
20202
20214
20222
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting7
Recruiting3
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
BioMarin Pharmaceutical4
Novartis Pharmaceuticals4
Pfizer3
Takeda3
Genzyme, a Sanofi Company2
Il-Yang Pharm. Co., Ltd.2
Amgen1
Ariad Pharmaceuticals1
Seagen Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Diseases31
Bone Marrow Diseases9
Hemorrhagic Disorders9
Leukemia8
Hemophilia A7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive7
Blood Coagulation Disorders6
Blood Coagulation Disorders, Inherited6
Coagulation Protein Disorders6
Genetic Diseases, Inborn6

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.